At Angiotech, we are redefining success by striving to create novel medical solutions that elevate the standard of care and improve people's lives.
Angiotech is Redefining Success
- Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP). Read More...
If you are a Healthcare Professional and would like to learn more about Angiotech's products, please visit AngioEduPRO.com; Angiotech's Educational Resource for Healthcare Professionals.
Press Releases
- July 10th - Angiotech Wins Before the UK House of Lords Read More...
- July 7th - Angiotech to Establish Separate Operating and Royalty Businesses Read More...
- July 7th - Angiotech to Commence Cash Tender for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes due 2014 Read More...
- All Press Releases
Highlights
- Angiotech to webcast a conference call discussing Second Quarter Financial Results on July 28th Read More...
- Angiotech participated in the Bank of America Health Care Conference in Las Vegas on May 14th Read More...
